Drug Profile
Secretin - 9 Meters Biopharma
Alternative Names: INN-329; RG 1068; SecreFloLatest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Repligen
- Developer 9 Meters Biopharma; Repligen Corporation
- Class Antipsychotics; Behavioural disorder therapies; Gastrointestinal hormones; Neuropeptides; Peptide diagnostics; Peptide hormones
- Mechanism of Action Emission-computed tomography enhancers; Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preregistration Submission Withdrawal Pancreatic disorders
- Discontinued Autistic disorder; Obsessive-compulsive disorders; Pancreatic cancer; Schizophrenia
Most Recent Events
- 21 Sep 2023 Discontinued - Phase-0 for Pancreatic cancer (Diagnosis) in USA (IV)
- 21 Sep 2023 Discontinued - Phase-II for Obsessive-compulsive disorders in USA (SC)
- 21 Sep 2023 Discontinued - Phase-III for Pancreatic disorders (Diagnosis) in Canada (IV)